LONDON--(BUSINESS WIRE)--The Clinical Decision Support System market will register an incremental spend of about $1,274 million, growing at a CAGR of 17.91% during the five-year forecast period. A ...
Giving voice to patients: Understanding treatment preferences of patients with multiple myeloma (MM). This is an ASCO Meeting Abstract from the 2019 ASCO Annual Meeting I. This abstract does not ...
To examine the impact of a clinical decision support system (CDSS) on breast cancer treatment decisions and adherence to National Comprehensive Cancer Center (NCCN) guidelines. A cross-sectional ...
With an artificial intelligence-powered medical search and decision support platform, the health system's physicians can access the latest clinical evidence for use in patient care.
Deployment of artificial intelligence for point-of-care clinical decision support is in its nascency. Despite the media attention and proliferation of AI studies, translation to clinical practice is ...
The global clinical decision support system market is projected to expand at an approximate CAGR of around 10% throughout the forecast timeline, supported by the rapid adoption of electronic health ...
The use of enabling technologies, such as artificial intelligence (AI), machine learning (ML) and natural language processing (NLP), for improving data preparation, insights generation and explanation ...
Decision intelligence is a new field that helps support, augment and automate business decisions by linking data with decisions and outcomes. It uses a combination of methods (e.g., decision mapping ...